---
title: "Australia's Artrya slips most in over 2 weeks on discounted placement"
date: "2025-02-14 09:54:31"
summary: "** Shares of Artrya fall 3.5% to A$0.83** Stock marks its worst intraday drop since January 29** The medtech co says it has received commitments to raise A$15 million ($9.48 million) via share placement at an issue price of A$0.73 apiece ** Issue price represents a discount of 17.8%, as..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Shares of Artrya fall 3.5% to A$0.83

\*\* Stock marks its worst intraday drop since January 29

\*\* The medtech co says it has received commitments to raise A$15 million ($9.48 million) via share placement at an issue price of A$0.73 apiece

\*\* Issue price represents a discount of 17.8%, as of the stock's last close

\*\* Says placement proceeds will be used to accelerate commercial adoption of its Salix software in new U.S. hospitals

\*\* Stock surged 70.8% in January

($1 = 1.5815 Australian dollars)

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P506K:0-australia-s-artrya-slips-most-in-over-2-weeks-on-discounted-placement/)
